ID   IRAK1_HUMAN             Reviewed;         633 AA.
AC   P51617-4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   12-OCT-2022, entry version 221.
DE   RecName: Full=Isoform 4 of Interleukin-1 receptor-associated kinase 1 {ECO:0000303|PubMed:16024789};
DE            Short=IRAK-1 {ECO:0000303|PubMed:16024789};
DE            EC=2.7.11.1;
GN   Name=IRAK1 {ECO:0000312|HGNC:HGNC:6112}; Synonyms=IRAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   VARIANTS SER-196 AND LEU-532.
RX   PubMed=8599092; DOI=10.1126/science.271.5252.1128;
RA   Cao Z., Henzel W.J., Gao X.;
RT   "IRAK: a kinase associated with the interleukin-1 receptor.";
RL   Science 271:1128-1131(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=10723722; DOI=10.1007/s003350010035;
RA   Reichwald K., Thiesen J., Wiehe T., Weitzel J., Poustka W.A., Rosenthal A.,
RA   Platzer M., Stratling W.H., Kioschis P.;
RT   "Comparative sequence analysis of the MECP2-locus in human and mouse
RT   reveals new transcribed regions.";
RL   Mamm. Genome 11:182-190(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY, AND
RP   PHOSPHORYLATION.
RX   PubMed=11397809; DOI=10.1074/jbc.m103815200;
RA   Jensen L.E., Whitehead A.S.;
RT   "IRAK1b, a novel alternative splice variant of interleukin-1 receptor-
RT   associated kinase (IRAK), mediates interleukin-1 signaling and has
RT   prolonged stability.";
RL   J. Biol. Chem. 276:29037-29044(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=16024789; DOI=10.1128/mcb.25.15.6521-6532.2005;
RA   Rao N., Nguyen S., Ngo K., Fung-Leung W.P.;
RT   "A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase
RT   1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory
RT   signaling.";
RL   Mol. Cell. Biol. 25:6521-6532(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH MYD88.
RX   PubMed=9430229; DOI=10.1016/s1074-7613(00)80402-1;
RA   Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z.;
RT   "MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.";
RL   Immunity 7:837-847(1997).
RN   [9]
RP   INTERACTION WITH TOLLIP.
RX   PubMed=10854325; DOI=10.1038/35014038;
RA   Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B.,
RA   Lewis A., Ray K., Tschopp J., Volpe F.;
RT   "Tollip, a new component of the IL-1R1 pathway, links IRAK to the IL-1
RT   receptor.";
RL   Nat. Cell Biol. 2:346-351(2000).
RN   [10]
RP   INTERACTION WITH IRAK4.
RX   PubMed=11960013; DOI=10.1073/pnas.082100399;
RA   Li S., Strelow A., Fontana E.J., Wesche H.;
RT   "IRAK4: a novel member of the IRAK family with the properties of an IRAK-
RT   kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5567-5572(2002).
RN   [11]
RP   INTERACTION WITH PELI1 AND TRAF6.
RX   PubMed=12496252; DOI=10.1074/jbc.m212112200;
RA   Jiang Z., Johnson H.J., Nie H., Qin J., Bird T.A., Li X.;
RT   "Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through
RT   its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-
RT   tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.";
RL   J. Biol. Chem. 278:10952-10956(2003).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF PELI2.
RX   PubMed=12860405; DOI=10.1016/s0014-5793(03)00697-5;
RA   Strelow A., Kollewe C., Wesche H.;
RT   "Characterization of Pellino2, a substrate of IRAK1 and IRAK4.";
RL   FEBS Lett. 547:157-161(2003).
RN   [13]
RP   PHOSPHORYLATION BY IRAK4.
RX   PubMed=12538665; DOI=10.1084/jem.20021790;
RA   Burns K., Janssens S., Brissoni B., Olivos N., Beyaert R., Tschopp J.;
RT   "Inhibition of interleukin 1 receptor/Toll-like receptor signaling through
RT   the alternatively spliced, short form of MyD88 is due to its failure to
RT   recruit IRAK-4.";
RL   J. Exp. Med. 197:263-268(2003).
RN   [14]
RP   INTERACTION WITH PELI3.
RX   PubMed=12874243; DOI=10.4049/jimmunol.171.3.1500;
RA   Jensen L.E., Whitehead A.S.;
RT   "Pellino3, a novel member of the Pellino protein family, promotes
RT   activation of c-Jun and Elk-1 and may act as a scaffolding protein.";
RL   J. Immunol. 171:1500-1506(2003).
RN   [15]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-66.
RX   PubMed=14684752; DOI=10.1074/jbc.c300431200;
RA   Mamidipudi V., Lin C., Seibenhener M.L., Wooten M.W.;
RT   "Regulation of interleukin receptor-associated kinase (IRAK)
RT   phosphorylation and signaling by iota protein kinase C.";
RL   J. Biol. Chem. 279:4161-4165(2004).
RN   [16]
RP   PHOSPHORYLATION AT THR-209 AND THR-387, DOMAIN, AND MUTAGENESIS OF THR-209
RP   AND THR-387.
RX   PubMed=14625308; DOI=10.1074/jbc.m309251200;
RA   Kollewe C., Mackensen A.C., Neumann D., Knop J., Cao P., Li S., Wesche H.,
RA   Martin M.U.;
RT   "Sequential autophosphorylation steps in the interleukin-1 receptor-
RT   associated kinase-1 regulate its availability as an adapter in interleukin-
RT   1 signaling.";
RL   J. Biol. Chem. 279:5227-5236(2004).
RN   [17]
RP   FUNCTION, AND MUTAGENESIS OF LYS-239.
RX   PubMed=15084582; DOI=10.1074/jbc.m400785200;
RA   Qin J., Jiang Z., Qian Y., Casanova J.-L., Li X.;
RT   "IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-
RT   associated kinase phosphorylation and IL-1 responsiveness.";
RL   J. Biol. Chem. 279:26748-26753(2004).
RN   [18]
RP   FUNCTION IN PHOSPHORYLATION OF STAT3.
RX   PubMed=15465816; DOI=10.1074/jbc.m410369200;
RA   Huang Y., Li T., Sane D.C., Li L.;
RT   "IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced
RT   interleukin-10 gene expression.";
RL   J. Biol. Chem. 279:51697-51703(2004).
RN   [19]
RP   INTERACTION WITH IL1RL1.
RX   PubMed=16286016; DOI=10.1016/j.immuni.2005.09.015;
RA   Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K.,
RA   Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F.,
RA   Kastelein R.A.;
RT   "IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-
RT   related protein ST 2 and induces T helper type 2-associated cytokines.";
RL   Immunity 23:479-490(2005).
RN   [20]
RP   FUNCTION IN PHOSPHORYLATION OF IRF7.
RX   PubMed=15767370; DOI=10.1084/jem.20042372;
RA   Uematsu S., Sato S., Yamamoto M., Hirotani T., Kato H., Takeshita F.,
RA   Matsuda M., Coban C., Ishii K.J., Kawai T., Takeuchi O., Akira S.;
RT   "Interleukin-1 receptor-associated kinase-1 plays an essential role for
RT   Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha}
RT   induction.";
RL   J. Exp. Med. 201:915-923(2005).
RN   [21]
RP   IDENTIFICATION IN COMPLEX WITH IRAK4; MYD88; PELI1 AND TRAF6.
RX   PubMed=16951688; DOI=10.1038/ni1383;
RA   Choi K.C., Lee Y.S., Lim S., Choi H.K., Lee C.H., Lee E.K., Hong S.,
RA   Kim I.H., Kim S.J., Park S.H.;
RT   "Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor
RT   signaling through direct interaction with the adapter Pellino-1.";
RL   Nat. Immunol. 7:1057-1065(2006).
RN   [22]
RP   SUMOYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=16690127; DOI=10.1016/j.molimm.2006.03.021;
RA   Su J., Richter K., Zhang C., Gu Q., Li L.;
RT   "Differential regulation of interleukin-1 receptor associated kinase 1
RT   (IRAK1) splice variants.";
RL   Mol. Immunol. 44:900-905(2007).
RN   [23]
RP   FUNCTION IN PHOSPHORYLATION OF PELI1.
RX   PubMed=17997719; DOI=10.1042/bj20071365;
RA   Ordureau A., Smith H., Windheim M., Peggie M., Carrick E., Morrice N.,
RA   Cohen P.;
RT   "The IRAK-catalysed activation of the E3 ligase function of Pellino
RT   isoforms induces the Lys63-linked polyubiquitination of IRAK1.";
RL   Biochem. J. 409:43-52(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [25]
RP   UBIQUITINATION AT LYS-134 AND LYS-180 BY TRAF6, AND INTERACTION WITH
RP   IKBKG/NEMO.
RX   PubMed=18347055; DOI=10.1128/mcb.02098-07;
RA   Conze D.B., Wu C.J., Thomas J.A., Landstrom A., Ashwell J.D.;
RT   "Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1
RT   receptor- and toll-like receptor-mediated NF-kappaB activation.";
RL   Mol. Cell. Biol. 28:3538-3547(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [27]
RP   UBIQUITINATION.
RX   PubMed=19675569; DOI=10.1038/nature08247;
RA   Xia Z.-P., Sun L., Chen X., Pineda G., Jiang X., Adhikari A., Zeng W.,
RA   Chen Z.J.;
RT   "Direct activation of protein kinases by unanchored polyubiquitin chains.";
RL   Nature 461:114-119(2009).
RN   [28]
RP   FUNCTION IN PHOSPHORYLATION OF TIRAP.
RX   PubMed=20400509; DOI=10.1074/jbc.m109.098137;
RA   Dunne A., Carpenter S., Brikos C., Gray P., Strelow A., Wesche H.,
RA   Morrice N., O'Neill L.A.;
RT   "IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation
RT   of MyD88 adaptor-like (Mal).";
RL   J. Biol. Chem. 285:18276-18282(2010).
RN   [29]
RP   REVIEW ON FUNCTION.
RX   PubMed=17890055; DOI=10.1016/j.cellsig.2007.08.009;
RA   Gottipati S., Rao N.L., Fung-Leung W.P.;
RT   "IRAK1: a critical signaling mediator of innate immunity.";
RL   Cell. Signal. 20:269-276(2008).
RN   [30]
RP   INTERACTION WITH NFATC4, AND MUTAGENESIS OF ASP-340.
RX   PubMed=18691762; DOI=10.1016/j.molimm.2008.06.023;
RA   Wang D., Fasciano S., Li L.;
RT   "The interleukin-1 receptor associated kinase 1 contributes to the
RT   regulation of NFAT.";
RL   Mol. Immunol. 45:3902-3908(2008).
RN   [31]
RP   REVIEW ON FUNCTION.
RX   PubMed=19022706; DOI=10.1016/j.it.2008.10.001;
RA   Moynagh P.N.;
RT   "The Pellino family: IRAK E3 ligases with emerging roles in innate immune
RT   signalling.";
RL   Trends Immunol. 30:33-42(2009).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-371; SER-375 AND SER-556, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [34]
RP   INTERACTION WITH INAVA.
RX   PubMed=28436939; DOI=10.1172/jci86282;
RA   Yan J., Hedl M., Abraham C.;
RT   "An inflammatory bowel disease-risk variant in INAVA decreases pattern
RT   recognition receptor-induced outcomes.";
RL   J. Clin. Invest. 127:2192-2205(2017).
RN   [35]
RP   INTERACTION WITH MUMPS VIRUS PROTEIN SH.
RX   PubMed=28659487; DOI=10.1128/jvi.01037-17;
RA   Franz S., Rennert P., Woznik M., Gruetzke J., Luedde A., Arriero Pais E.M.,
RA   Finsterbusch T., Geyer H., Mankertz A., Friedrich N.;
RT   "Mumps virus SH protein inhibits NF-kappaB activation by interacting with
RT   tumor necrosis factor receptor 1, interleukin-1 receptor 1, and Toll-like
RT   receptor 3 complexes.";
RL   J. Virol. 91:0-0(2017).
RN   [36]
RP   INTERACTION WITH PELI1.
RX   PubMed=29883609; DOI=10.1016/j.molcel.2018.05.016;
RA   Choi S.W., Park H.H., Kim S., Chung J.M., Noh H.J., Kim S.K., Song H.K.,
RA   Lee C.W., Morgan M.J., Kang H.C., Kim Y.S.;
RT   "PELI1 selectively targets kinase-active RIP3 for ubiquitylation-dependent
RT   proteasomal degradation.";
RL   Mol. Cell 70:920-935(2018).
RN   [37]
RP   INTERACTION WITH ALPHAVIRUS CAPSID PROTEINS (MICROBIAL INFECTION).
RX   PubMed=33673546; DOI=10.3390/v13030377;
RA   Landers V.D., Wilkey D.W., Merchant M.L., Mitchell T.C., Sokoloski K.J.;
RT   "The Alphaviral Capsid Protein Inhibits IRAK1-Dependent TLR Signaling.";
RL   Viruses 13:0-0(2021).
RN   [38]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-398; MET-412; HIS-421; LEU-532;
RP   SER-619; MET-625; TRP-638 AND GLY-690.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=a;
CC         IsoId=P51617-1; Sequence=Displayed;
CC       Name=2; Synonyms=b;
CC         IsoId=P51617-2; Sequence=VSP_011851;
CC       Name=3;
CC         IsoId=P51617-3; Sequence=VSP_011849, VSP_011850, VSP_011851;
CC       Name=4;
CC         IsoId=P51617-4; Sequence=VSP_041950;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS35443.1; -.
DR   RefSeq; NP_001020414.1; NM_001025243.1.
DR   ProteomicsDB; 56352; -.
DR   Ensembl; ENST00000369974.6; ENSP00000358991.2; ENSG00000184216.14.
DR   Proteomes; UP000005640; Chromosome X.
PE   1: Evidence at protein level;
SQ   SEQUENCE   633 AA;  68022 MW;  419926E55C935F38 CRC64;
     MAGGPGPGEP AAPGAQHFLY EVPPWVMCRF YKVMDALEPA DWCQFAALIV RDQTELRLCE
     RSGQRTASVL WPWINRNARV ADLVHILTHL QLLRARDIIT AWHPPAPLPS PGTTAPRPSS
     IPAPAEAEAW SPRKLPSSAS TFLSPAFPGS QTHSGPELGL VPSPASLWPP PPSPAPSSTK
     PGPESSVSLL QGARPFPFCW PLCEISRGTH NFSEELKIGE GGFGCVYRAV MRNTVYAVKR
     LKENADLEWT AVKQSFLTEV EQLSRFRHPN IVDFAGYCAQ NGFYCLVYGF LPNGSLEDRL
     HCQTQACPPL SWPQRLDILL GTARAIQFLH QDSPSLIHGD IKSSNVLLDE RLTPKLGDFG
     LARFSRFAGS SPSQSSMVAR TQTVRGTLAY LPEEYIKTGR LAVDTDTFSF GVVVLETLAG
     QRAVKTHGAR TKYLVYERLE KLQAVVAGVP GHSEAASCIP PSPQENSYVS STGRAHSGAA
     PWQPLAAPSG ASAQAAEQLQ RGPNQPVESD ESLGGLSAAL RSWHLTPSCP LDPAPLREAG
     CPQGDTAGES SWGSGPGSRP TAVEGLALGS SASSSSEPPQ IIINPARQKM VQKLALYEDG
     ALDSLQLLSS SSLPGLGLEQ DRQGPEESDE FQS
//
